These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2000109)

  • 1. A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation.
    Kendig JW; Notter RH; Cox C; Reubens LJ; Davis JM; Maniscalco WM; Sinkin RA; Bartoletti A; Dweck HS; Horgan MJ
    N Engl J Med; 1991 Mar; 324(13):865-71. PubMed ID: 2000109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomized controlled trial of prophylaxis versus treatment.
    Dunn MS; Shennan AT; Zayack D; Possmayer F
    Pediatrics; 1991 Mar; 87(3):377-86. PubMed ID: 2000278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome.
    Horbar JD; Soll RF; Sutherland JM; Kotagal U; Philip AG; Kessler DL; Little GA; Edwards WH; Vidyasagar D; Raju TN
    N Engl J Med; 1989 Apr; 320(15):959-65. PubMed ID: 2648150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation.
    Kattwinkel J; Bloom BT; Delmore P; Davis CL; Farrell E; Friss H; Jung AL; King K; Mueller D
    Pediatrics; 1993 Jul; 92(1):90-8. PubMed ID: 8516091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group.
    Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP
    Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
    de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
    Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An observational study of surfactant treatment in infants of 23-30 weeks' gestation: comparison of prophylaxis and early rescue.
    Bevilacqua G; Parmigiani S;
    J Matern Fetal Neonatal Med; 2003 Sep; 14(3):197-204. PubMed ID: 14694975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal CPAP or intubation at birth for very preterm infants.
    Morley CJ; Davis PG; Doyle LW; Brion LP; Hascoet JM; Carlin JB;
    N Engl J Med; 2008 Feb; 358(7):700-8. PubMed ID: 18272893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two strategies for surfactant prophylaxis in very premature infants: a multicenter randomized trial.
    Kendig JW; Ryan RM; Sinkin RA; Maniscalco WM; Notter RH; Guillet R; Cox C; Dweck HS; Horgan MJ; Reubens LJ; Risemberg H; Phelps DL
    Pediatrics; 1998 Jun; 101(6):1006-12. PubMed ID: 9606227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of prophylaxis and rescue treatment with Curosurf in neonates less than 30 weeks' gestation: a randomized trial.
    Egberts J; de Winter JP; Sedin G; de Kleine MJ; Broberger U; van Bel F; Curstedt T; Robertson B
    Pediatrics; 1993 Dec; 92(6):768-74. PubMed ID: 8233735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective surfactant prophylaxis in preterm infants born at < or =31 weeks' gestation using the stable microbubble test in gastric aspirates.
    Fiori HH; Fritscher CC; Fiori RM
    J Perinat Med; 2006; 34(1):66-70. PubMed ID: 16489887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased respiratory compliance in infants less than or equal to 32 weeks' gestation, delivered more than 7 days after antenatal steroid therapy.
    McEvoy C; Schilling D; Spitale P; Peters D; O'Malley J; Durand M
    Pediatrics; 2008 May; 121(5):e1032-8. PubMed ID: 18450845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery room continuous positive airway pressure/positive end-expiratory pressure in extremely low birth weight infants: a feasibility trial.
    Finer NN; Carlo WA; Duara S; Fanaroff AA; Donovan EF; Wright LL; Kandefer S; Poole WK;
    Pediatrics; 2004 Sep; 114(3):651-7. PubMed ID: 15342835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
    N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind, randomized trial of a calf lung surfactant extract administered at birth to very premature infants for prevention of respiratory distress syndrome.
    Shapiro DL; Notter RH; Morin FC; Deluga KS; Golub LM; Sinkin RA; Weiss KI; Cox C
    Pediatrics; 1985 Oct; 76(4):593-9. PubMed ID: 3900907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial.
    Rojas MA; Lozano JM; Rojas MX; Laughon M; Bose CL; Rondon MA; Charry L; Bastidas JA; Perez LA; Rojas C; Ovalle O; Celis LA; Garcia-Harker J; Jaramillo ML;
    Pediatrics; 2009 Jan; 123(1):137-42. PubMed ID: 19117872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study.
    Kari MA; Hallman M; Eronen M; Teramo K; Virtanen M; Koivisto M; Ikonen RS
    Pediatrics; 1994 May; 93(5):730-6. PubMed ID: 8165070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic nasal continuous positive airways pressure in newborns of 28-31 weeks gestation: multicentre randomised controlled clinical trial.
    Sandri F; Ancora G; Lanzoni A; Tagliabue P; Colnaghi M; Ventura ML; Rinaldi M; Mondello I; Gancia P; Salvioli GP; Orzalesi M; Mosca F
    Arch Dis Child Fetal Neonatal Ed; 2004 Sep; 89(5):F394-8. PubMed ID: 15321956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeat surfactant therapy for postsurfactant slump.
    Katz LA; Klein JM
    J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
    Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
    Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.